These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6778191)

  • 1. Tocainide for drug-resistant ventricular arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide success.
    Winkle RA; Mason JW; Harrison DC
    Am Heart J; 1980 Dec; 100(6 Pt 2):1031-6. PubMed ID: 6778191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocainide therapy for refractory ventricular arrhythmias.
    Roden DM; Roden DM; Reele SB; Reele SB; Higgins SB; Higgins SB; Carr RK; Carr RK; Smith RF; Smith RF; Oates JA; Oates JA; Woosley RL; Woosley RL
    Am Heart J; 1980 Jul; 100(1):15-22. PubMed ID: 6770666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term tocainide therapy for ventricular arrhythmias.
    Winkle RA; Meffin PJ; Harrison DC
    Circulation; 1978 May; 57(5):1008-16. PubMed ID: 639200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerance of tocainide during long-term treatment of malignant ventricular arrhythmias.
    Mohiuddin SM; Esterbrooks D; Mooss AN; Dahl JM; Hilleman DE
    Clin Cardiol; 1987 Aug; 10(8):457-62. PubMed ID: 3113792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocainide for refractory symptomatic ventricular arrhythmias.
    Podrid PJ; Lown B
    Am J Cardiol; 1982 Apr; 49(5):1279-86. PubMed ID: 6801955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocainide for drug-resistant sustained ventricular tachyarrhythmias.
    Adhar GC; Swerdlow CD; Lance BL; Clay D; Bardy GH; Greene HL
    J Am Coll Cardiol; 1988 Jan; 11(1):124-31. PubMed ID: 3121711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open clinical studies at a referral center: chronic maintenance tocainide therapy in patients with recurrent sustained ventricular tachycardia refractory to conventional antiarrhythmic agents.
    Maloney JD; Nissen RG; McColgan JM
    Am Heart J; 1980 Dec; 100(6 Pt 2):1023-30. PubMed ID: 6778190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW
    Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias.
    Ryan W; Engler R; LeWinter M; Karliner JS
    Am J Cardiol; 1979 Feb; 43(2):285-91. PubMed ID: 760482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocainide: a new oral antiarrhythmic.
    Hasegawa GR
    Drug Intell Clin Pharm; 1985; 19(7-8):514-7. PubMed ID: 3928308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocainide for refractory ventricular arrhythmias of myocardial infarction.
    Haffajee CI; Alpert JS; Dalen JE
    Am Heart J; 1980 Dec; 100(6 Pt 2):1013-6. PubMed ID: 6778188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.
    Allen-Narker RA; Roberts CJ; Marshall AJ; Jordan SC; Barritt DW; Goodfellow RM
    Br J Clin Pharmacol; 1984 Nov; 18(5):725-32. PubMed ID: 6439233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ; Easley AR; Mann DE
    Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of ventricular arrhythmias with oral tocainide.
    Young MD; Hadidian Z; Horn HR; Johnson JL; Vassallo HG
    Am Heart J; 1980 Dec; 100(6 Pt 2):1041-5. PubMed ID: 6778193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Oshrain C; Steele PP
    Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
    Kreeger RW; Hammill SC
    Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic tocainide therapy for refractory high-grade ventricular arrhythmias.
    Haffajee CI; Sacks GM; Alpert JS; Howe JP; Ockene IS; Paraskos JA; Dalen JE
    Clin Cardiol; 1983 Feb; 6(2):72-8. PubMed ID: 6403267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic efficacy, pharmacokinetics and clinical safety of tocainide in convalescent myocardial infarction patients.
    Klein MD; Levine PA; Ryan TJ
    Chest; 1980 Jun; 77(6):726-30. PubMed ID: 6772381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term therapy with tocainide for malignant ventricular tachyarrhythmias.
    Hohnloser SH; Lange HW; Raeder EA; Podrid PJ; Lown B
    Circulation; 1986 Jan; 73(1):143-9. PubMed ID: 3079677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.